Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Psoriasis 1Congenital Abnormalities 1Autoimmune Diseases 1Arthritis, Psoriatic 1

Interventions

fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 63Cyclophosphamide 59Busulfan 51Tacrolimus 46Mycophenolic Acid 46Cytarabine 44Whole-Body Irradiation 41Cyclosporine 37Methotrexate 34Antilymphocyte Serum 33Filgrastim 30Etoposide 29Radiotherapy 22Melphalan 21Flow Cytometry 21Cord Blood Stem Cell Transplantation 17Mitoxantrone 14Methylprednisolone 14Transplantation 13Granulocyte Colony-Stimulating Factor 12Idarubicin 11Clofarabine 11sargramostim 10aldesleukin 10Thiotepa 9Polymerase Chain Reaction 9Alemtuzumab 9merphos 8Therapeutics 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Congenital Abnormalities × apremilast × Clear all
NCT02775500 2025-01-28

Apremilast Pregnancy Exposure Registry

University of California, San Diego

Active not recruiting
233 enrolled

Congenital Abnormalities, Autoimmune Diseases, Psoriasis, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡